seqnames,start,end,DISEASE/TRAIT,SNPS
1,182112825,182112825,Cardiovascular heart disease in diabetics,rs10911021
1,109275216,109275216,Cardiovascular disease risk factors,rs660240
1,101544358,101544358,Circulating leptin levels x sex interaction in high cardiovascular risk,rs1146714
1,34530812,34530812,Circulating leptin levels in high cardiovascular risk,rs10737381
1,23775590,23775590,Circulating leptin levels in high cardiovascular risk,rs11591202
1,109274570,109274570,Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease,rs7528419
1,173026503,173026503,Myocardial infarction in darapladib-treated cardiovascular disease (time to event),rs201052613
1,109274968,109274968,Lipoprotein phospholipase A2 activity in cardiovascular disease,rs12740374
1,210587100,210587100,Cardiovascular disease in hypertension (ACE inhibitor interaction),rs4077408
1,227120115,227120115,Cardiovascular death or myocardial infarction in response to clopidogrel treatment,rs115346894
1,227236411,227236411,Cardiovascular death or myocardial infarction in response to clopidogrel treatment,rs139496757
1,109960674,109960674,Blood protein levels in cardiovascular risk,rs17610659
1,12183768,12183768,Blood protein levels in cardiovascular risk,rs76769120
1,26807930,26807930,Blood protein levels in cardiovascular risk,rs35538083
1,11856038,11856038,Blood protein levels in cardiovascular risk,rs549596
1,11857564,11857564,Blood protein levels in cardiovascular risk,rs35207557
1,203199346,203199346,Blood protein levels in cardiovascular risk,rs2153101
1,154453788,154453788,Blood protein levels in cardiovascular risk,rs4129267
1,204641544,204641544,Blood protein levels in cardiovascular risk,rs116661163
1,166516654,166516654,Cardiovascular event in rheumatoid arthritis,rs6684311
1,3410468,3410468,Cardiovascular disease,rs2493296
1,6616425,6616425,Cardiovascular disease,rs12731208
1,8587858,8587858,Cardiovascular disease,rs6670508
1,10736809,10736809,Cardiovascular disease,rs880315
1,11825590,11825590,Cardiovascular disease,rs56153133
1,16093094,16093094,Cardiovascular disease,rs28711771
1,24703979,24703979,Cardiovascular disease,rs6686889
1,25068642,25068642,Cardiovascular disease,rs448385
1,26842709,26842709,Cardiovascular disease,rs71636784
1,42041342,42041342,Cardiovascular disease,rs12758407
1,55039974,55039974,Cardiovascular disease,rs11591147
1,56163763,56163763,Cardiovascular disease,rs1149643
1,56549996,56549996,Cardiovascular disease,rs61772626
1,62456989,62456989,Cardiovascular disease,rs4350231
1,72287256,72287256,Cardiovascular disease,rs2613498
1,88897581,88897581,Cardiovascular disease,rs6679817
1,109274968,109274968,Cardiovascular disease,rs12740374
1,112504257,112504257,Cardiovascular disease,rs3790604
1,115284645,115284645,Cardiovascular disease,rs59980837
1,153689947,153689947,Cardiovascular disease,rs35479618
1,193326609,193326609,Cardiovascular disease,rs16835282
1,201814554,201814554,Cardiovascular disease,rs2820290
1,228003374,228003374,Cardiovascular disease,rs2760061
1,230701298,230701298,Cardiovascular disease,rs943580
1,232394844,232394844,Cardiovascular disease,rs6683021
2,21021128,21021128,Cardiovascular disease risk factors,rs10199768
2,27508073,27508073,Cardiovascular disease risk factors,rs1260326
2,236081413,236081413,Cardiovascular disease in hypertension (calcium channel blocker interaction),rs3768939
2,71884400,71884400,Cardiovascular death or myocardial infarction in response to clopidogrel treatment,rs7584466
2,32636488,32636488,Blood protein levels in cardiovascular risk,rs7599125
2,31643808,31643808,Blood protein levels in cardiovascular risk,rs693918
2,27508073,27508073,Blood protein levels in cardiovascular risk,rs1260326
2,102341256,102341256,Blood protein levels in cardiovascular risk,rs1420101
2,60266350,60266350,Blood protein levels in cardiovascular risk,rs4672375
2,241776965,241776965,Blood protein levels in cardiovascular risk,rs12469459
2,20567381,20567381,Cardiovascular disease,rs113898337
2,21041028,21041028,Cardiovascular disease,rs1367117
2,21205177,21205177,Cardiovascular disease,rs312053
2,25018517,25018517,Cardiovascular disease,rs188315257
2,26691496,26691496,Cardiovascular disease,rs1275988
2,27519736,27519736,Cardiovascular disease,rs780093
2,28424836,28424836,Cardiovascular disease,rs67385572
2,42969554,42969554,Cardiovascular disease,rs115262049
2,43505819,43505819,Cardiovascular disease,rs3764769
2,43845437,43845437,Cardiovascular disease,rs4299376
2,45651621,45651621,Cardiovascular disease,rs687914
2,58606358,58606358,Cardiovascular disease,rs6731302
2,61435420,61435420,Cardiovascular disease,rs1186699
2,65049318,65049318,Cardiovascular disease,rs1009358
2,85983150,85983150,Cardiovascular disease,rs3937593
2,120590036,120590036,Cardiovascular disease,rs11688682
2,158455064,158455064,Cardiovascular disease,rs55873205
2,164191395,164191395,Cardiovascular disease,rs13021222
2,218277768,218277768,Cardiovascular disease,rs2271543
2,218835276,218835276,Cardiovascular disease,rs78058190
2,226243730,226243730,Cardiovascular disease,rs2943652
3,165773492,165773492,Cardiovascular disease risk factors,rs1803274
3,189796258,189796258,Circulating leptin levels in high cardiovascular risk,rs1515495
3,98531371,98531371,Circulating leptin levels in high cardiovascular risk,rs4857399
3,183010881,183010881,Circulating leptin levels in high cardiovascular risk,rs4074110
3,132148683,132148683,Circulating leptin levels in high cardiovascular risk,rs3914906
3,98531371,98531371,Circulating leptin levels in high cardiovascular risk,rs4857399
3,60942161,60942161,Major coronary event in placebo-treated cardiovascular disease (time to event),rs138741635
3,60942161,60942161,Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction),rs138741635
3,15633655,15633655,Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event),rs11915606
3,45780518,45780518,Blood protein levels in cardiovascular risk,rs73062378
3,172516227,172516227,Blood protein levels in cardiovascular risk,rs142552223
3,46373484,46373484,Blood protein levels in cardiovascular risk,rs62625034
3,11467491,11467491,Cardiovascular disease,rs6781726
3,14865227,14865227,Cardiovascular disease,rs2131570
3,27521497,27521497,Cardiovascular disease,rs2643826
3,48132720,48132720,Cardiovascular disease,rs6800730
3,53523985,53523985,Cardiovascular disease,rs3821843
3,53700504,53700504,Cardiovascular disease,rs6445597
3,53815978,53815978,Cardiovascular disease,rs11130381
3,128075405,128075405,Cardiovascular disease,rs11709060
3,134274473,134274473,Cardiovascular disease,rs4682671
3,136206349,136206349,Cardiovascular disease,rs1154988
3,138403280,138403280,Cardiovascular disease,rs9818870
3,150379848,150379848,Cardiovascular disease,rs9844972
3,158564670,158564670,Cardiovascular disease,rs6441207
3,160548029,160548029,Cardiovascular disease,rs75943566
3,169139845,169139845,Cardiovascular disease,rs78307470
3,169411863,169411863,Cardiovascular disease,rs2421648
3,169577976,169577976,Cardiovascular disease,rs6770911
3,184187521,184187521,Cardiovascular disease,rs35315125
4,88124179,88124179,Cardiovascular disease risk factors,rs2199936
4,10054752,10054752,Cardiovascular disease risk factors,rs7671266
4,10329670,10329670,Cardiovascular disease risk factors,rs4698036
4,124644124,124644124,Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction),rs192427471
4,124644124,124644124,Major coronary event in darapladib-treated cardiovascular disease (time to event),rs192427471
4,47371654,47371654,Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event),rs148121703
4,38941227,38941227,Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event),rs144610116
4,87834676,87834676,Cardiovascular disease risk factors,rs7698623
4,146249405,146249405,Cardiovascular death or myocardial infarction in response to clopidogrel treatment,rs13147128
4,73807847,73807847,Blood protein levels in cardiovascular risk,rs72650832
4,73868964,73868964,Blood protein levels in cardiovascular risk,rs74544699
4,82913620,82913620,Cardiovascular disease,rs35895091
4,95165950,95165950,Cardiovascular disease,rs7694531
4,99318162,99318162,Cardiovascular disease,rs1229984
4,102000547,102000547,Cardiovascular disease,rs13127398
4,102974066,102974066,Cardiovascular disease,rs7681002
4,105989801,105989801,Cardiovascular disease,rs56388530
4,110467945,110467945,Cardiovascular disease,rs7685862
4,137518476,137518476,Cardiovascular disease,rs9330353
4,143266227,143266227,Cardiovascular disease,rs893929
4,155499453,155499453,Cardiovascular disease,rs6536076
4,155725188,155725188,Cardiovascular disease,rs11724647
4,15019561,15019561,Cardiovascular disease,rs9291634
4,3442204,3442204,Cardiovascular disease,rs13108218
4,17862391,17862391,Cardiovascular disease,rs58854324
4,26587448,26587448,Cardiovascular disease,rs1826063
4,38357696,38357696,Cardiovascular disease,rs6819003
4,80253438,80253438,Cardiovascular disease,rs13125101
5,169018484,169018484,Circulating leptin levels x sex interaction in high cardiovascular risk,rs11954861
5,169018484,169018484,Circulating leptin levels in high cardiovascular risk,rs11954861
5,117697919,117697919,Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event),rs201394051
5,1877166,1877166,Cardiovascular disease risk factors,rs4975709
5,78725395,78725395,"Cardiovascular death, myocardial infarction or stroke in response to clopidogrel treatment",rs7714373
5,153870393,153870393,Blood protein levels in cardiovascular risk,rs184243355
5,157045138,157045138,Blood protein levels in cardiovascular risk,rs6555820
5,75360714,75360714,Cardiovascular disease,rs12916
5,78550731,78550731,Cardiovascular disease,rs10942863
5,88477501,88477501,Cardiovascular disease,rs10042590
5,96823820,96823820,Cardiovascular disease,rs35134
5,114549599,114549599,Cardiovascular disease,rs7736264
5,123121430,123121430,Cardiovascular disease,rs74661587
5,128521800,128521800,Cardiovascular disease,rs17677603
5,132478399,132478399,Cardiovascular disease,rs7719499
5,133108436,133108436,Cardiovascular disease,rs72801474
5,156955297,156955297,Cardiovascular disease,rs4704825
5,158067851,158067851,Cardiovascular disease,rs2962383
5,158169198,158169198,Cardiovascular disease,rs150532297
5,158397473,158397473,Cardiovascular disease,rs7701003
5,158511062,158511062,Cardiovascular disease,rs13358657
5,159017266,159017266,Cardiovascular disease,rs36071027
5,173870299,173870299,Cardiovascular disease,rs72810955
5,177310719,177310719,Cardiovascular disease,rs13190036
5,3704137,3704137,Cardiovascular disease,rs34681481
5,32672675,32672675,Cardiovascular disease,rs2859814
5,32832368,32832368,Cardiovascular disease,rs10059884
5,53976834,53976834,Cardiovascular disease,rs4865796
5,56572270,56572270,Cardiovascular disease,rs13179413
5,64440647,64440647,Cardiovascular disease,rs271695
5,68403865,68403865,Cardiovascular disease,rs7721613
5,68747416,68747416,Cardiovascular disease,rs9291932
6,25776721,25776721,Cardiovascular disease risk factors,rs11754288
6,26092913,26092913,Cardiovascular disease risk factors,rs1800562
6,32610112,32610112,Circulating leptin levels in high cardiovascular risk,rs9271170
6,146805738,146805738,Circulating leptin levels in high cardiovascular risk,rs9390422
6,168603339,168603339,Circulating leptin levels in high cardiovascular risk,rs12530037
6,38925377,38925377,Circulating leptin levels in high cardiovascular risk,rs9394554
6,146805738,146805738,Circulating leptin levels in high cardiovascular risk,rs9390422
6,46709361,46709361,Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease,rs76863441
6,126276990,126276990,Diarrhoea in darapladib-treated cardiovascular disease (time to event),rs149232047
6,140064258,140064258,Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction),rs181937009
6,46709361,46709361,Lipoprotein phospholipase A2 activity in cardiovascular disease,rs76863441
6,160330499,160330499,Lipoprotein phospholipase A2 activity in cardiovascular disease,rs9295128
6,160589086,160589086,Lipoprotein phospholipase A2 activity in cardiovascular disease,rs10455872
6,160690668,160690668,Lipoprotein phospholipase A2 activity in cardiovascular disease,rs186696265
6,66873865,66873865,Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event),rs4357117
6,41655295,41655295,Cardiovascular disease risk factors,rs2143678
6,39147637,39147637,Cardiovascular disease in hypertension (calcium channel blocker interaction),rs7751419
6,32183666,32183666,Blood protein levels in cardiovascular risk,rs2070600
6,32405408,32405408,Blood protein levels in cardiovascular risk,rs10947260
6,108489362,108489362,Blood protein levels in cardiovascular risk,rs61598054
6,78773529,78773529,Cardiovascular disease,rs1507151
6,126834566,126834566,Cardiovascular disease,rs13210511
6,133863834,133863834,Cardiovascular disease,rs2105092
6,135126635,135126635,Cardiovascular disease,rs9321485
6,139509081,139509081,Cardiovascular disease,rs607342
6,142859589,142859589,Cardiovascular disease,rs62430713
6,150654176,150654176,Cardiovascular disease,rs62434109
6,151534458,151534458,Cardiovascular disease,rs10872673
6,160591981,160591981,Cardiovascular disease,rs140570886
6,165748847,165748847,Cardiovascular disease,rs2934849
6,1619912,1619912,Cardiovascular disease,rs2569882
6,20686765,20686765,Cardiovascular disease,rs9368222
6,22056694,22056694,Cardiovascular disease,rs2294214
6,22392594,22392594,Cardiovascular disease,rs2744132
6,43381570,43381570,Cardiovascular disease,rs7763350
6,43791136,43791136,Cardiovascular disease,rs6905288
6,50335316,50335316,Cardiovascular disease,rs1845034
6,51969222,51969222,Cardiovascular disease,rs1581717
7,29169736,29169736,Circulating leptin levels in high cardiovascular risk,rs245908
7,7995866,7995866,Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event),rs145044782
7,86058899,86058899,Cardiovascular death or myocardial infarction in response to clopidogrel treatment,rs151062494
7,86193546,86193546,Cardiovascular death or myocardial infarction in response to clopidogrel treatment,rs112858730
7,76284324,76284324,Blood protein levels in cardiovascular risk,rs13236526
7,1156056,1156056,Cardiovascular disease,rs73033340
7,1859811,1859811,Cardiovascular disease,rs11770148
7,2494758,2494758,Cardiovascular disease,rs2969037
7,7237584,7237584,Cardiovascular disease,rs11771259
7,27206274,27206274,Cardiovascular disease,rs3735533
7,27532326,27532326,Cardiovascular disease,rs11767188
7,44542387,44542387,Cardiovascular disease,rs17725246
7,74683722,74683722,Cardiovascular disease,rs7794284
7,92600848,92600848,Cardiovascular disease,rs740047
7,106771412,106771412,Cardiovascular disease,rs17477177
7,122434362,122434362,Cardiovascular disease,rs983521
7,130023656,130023656,Cardiovascular disease,rs11556924
7,130739451,130739451,Cardiovascular disease,rs6974288
7,134509749,134509749,Cardiovascular disease,rs782520
7,139767877,139767877,Cardiovascular disease,rs28656273
7,150993088,150993088,Cardiovascular disease,rs3918226
7,151716108,151716108,Cardiovascular disease,rs10224210
8,19992246,19992246,Cardiovascular disease risk factors,rs17091905
8,19992246,19992246,Cardiovascular disease risk factors,rs17091905
8,19962213,19962213,Lipoprotein phospholipase A2 activity in cardiovascular disease,rs328
8,137210487,137210487,"Cardiovascular death, myocardial infarction or stroke in response to clopidogrel treatment",rs35323955
8,119111105,119111105,Blood protein levels in cardiovascular risk,rs6469811
8,105577019,105577019,Blood protein levels in cardiovascular risk,rs16873402
8,23373385,23373385,Blood protein levels in cardiovascular risk,rs6557662
8,125487789,125487789,Blood protein levels in cardiovascular risk,rs28601761
8,119111583,119111583,Blood protein levels in cardiovascular risk,rs7813952
8,105569300,105569300,Blood protein levels in cardiovascular risk,rs6993770
8,20048393,20048393,Cardiovascular disease,rs78299715
8,26042889,26042889,Cardiovascular disease,rs73563812
8,26542619,26542619,Cardiovascular disease,rs10107066
8,31067041,31067041,Cardiovascular disease,rs1800389
8,58399138,58399138,Cardiovascular disease,rs1030431
8,75804502,75804502,Cardiovascular disease,rs2977324
8,81912028,81912028,Cardiovascular disease,rs13265769
8,94959692,94959692,Cardiovascular disease,rs2011567
8,101803258,101803258,Cardiovascular disease,rs1074703
8,104954030,104954030,Cardiovascular disease,rs35783704
8,125487789,125487789,Cardiovascular disease,rs28601761
8,128400582,128400582,Cardiovascular disease,rs7841408
8,142916379,142916379,Cardiovascular disease,rs11781816
9,37590253,37590253,Lipoprotein phospholipase A2 activity in cardiovascular disease,rs57578064
9,104634643,104634643,Lipoprotein phospholipase A2 activity in cardiovascular disease,rs189889864
9,77012344,77012344,Moderate or severe diarrhoea in darapladib-treated cardiovascular disease (time to event),rs62568141
9,14723628,14723628,Cardiovascular death or myocardial infarction in response to clopidogrel treatment,rs55670713
9,133279294,133279294,Blood protein levels in cardiovascular risk,rs495828
9,133279427,133279427,Blood protein levels in cardiovascular risk,rs635634
9,133262254,133262254,Blood protein levels in cardiovascular risk,rs8176693
9,133256074,133256074,Blood protein levels in cardiovascular risk,rs8176741
9,27191570,27191570,Blood protein levels in cardiovascular risk,rs79250370
9,133279427,133279427,Blood protein levels in cardiovascular risk,rs635634
9,14735055,14735055,Cardiovascular disease,rs1048070
9,19376260,19376260,Cardiovascular disease,rs67906804
9,35906474,35906474,Cardiovascular disease,rs76452347
9,37129499,37129499,Cardiovascular disease,rs13285624
9,109998608,109998608,Cardiovascular disease,rs10816914
9,110487920,110487920,Cardiovascular disease,rs76038906
9,133657152,133657152,Cardiovascular disease,rs6271
10,107120697,107120697,Circulating leptin levels in high cardiovascular risk,rs607437
10,58485924,58485924,Circulating leptin levels in high cardiovascular risk,rs10763548
10,121425789,121425789,Circulating leptin levels in high cardiovascular risk,rs10749415
10,51474417,51474417,"Cardiovascular death, myocardial infarction or stroke in response to clopidogrel treatment",rs7086422
10,100045685,100045685,Blood protein levels in cardiovascular risk,rs11599750
10,48722715,48722715,Blood protein levels in cardiovascular risk,rs76519098
10,89010241,89010241,Blood protein levels in cardiovascular risk,rs982764
10,44896515,44896515,Cardiovascular disease,rs7099692
10,58828793,58828793,Cardiovascular disease,rs4948550
10,61755923,61755923,Cardiovascular disease,rs72831343
10,62182180,62182180,Cardiovascular disease,rs10821967
10,62805132,62805132,Cardiovascular disease,rs2236295
10,74261866,74261866,Cardiovascular disease,rs10824134
10,86412952,86412952,Cardiovascular disease,rs2114820
10,94132902,94132902,Cardiovascular disease,rs10882397
10,94254865,94254865,Cardiovascular disease,rs10786156
10,95494548,95494548,Cardiovascular disease,rs943346
10,100315722,100315722,Cardiovascular disease,rs603424
10,100794914,100794914,Cardiovascular disease,rs10748798
10,103146454,103146454,Cardiovascular disease,rs11191580
10,104870101,104870101,Cardiovascular disease,rs145158522
10,110281821,110281821,Cardiovascular disease,rs2855469
10,114045297,114045297,Cardiovascular disease,rs1801253
10,121240352,121240352,Cardiovascular disease,rs12358504
10,132600079,132600079,Cardiovascular disease,rs75523587
10,18156159,18156159,Cardiovascular disease,rs10740995
10,18439030,18439030,Cardiovascular disease,rs12258967
10,27963710,27963710,Cardiovascular disease,rs1962094
11,117204850,117204850,Cardiovascular disease risk factors,rs508487
11,116742944,116742944,Cardiovascular risk factors (age interaction),rs12280753
11,122083949,122083949,Cardiovascular risk factors (age interaction),rs7121446
11,133614359,133614359,Circulating leptin levels in high cardiovascular risk,rs4937802
11,133614359,133614359,Circulating leptin levels in high cardiovascular risk,rs4937802
11,26141193,26141193,Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction),rs12290663
11,26141193,26141193,Major coronary event in darapladib-treated cardiovascular disease (time to event),rs12290663
11,117286177,117286177,Cardiovascular disease risk factors,rs1047964
11,12239165,12239165,"Cardiovascular death, myocardial infarction or stroke in response to clopidogrel treatment",rs11604904
11,39949536,39949536,Cardiovascular death or myocardial infarction in response to clopidogrel treatment,rs11035623
11,126357828,126357828,Blood protein levels in cardiovascular risk,rs7928577
11,10349128,10349128,Blood protein levels in cardiovascular risk,rs1580006
11,14017074,14017074,Blood protein levels in cardiovascular risk,rs1969539
11,102828729,102828729,Blood protein levels in cardiovascular risk,rs7946057
11,102827000,102827000,Blood protein levels in cardiovascular risk,rs471994
11,57403526,57403526,Blood protein levels in cardiovascular risk,rs140000161
11,1748994,1748994,Blood protein levels in cardiovascular risk,rs111693235
11,112181471,112181471,Blood protein levels in cardiovascular risk,rs75649625
11,102872031,102872031,Blood protein levels in cardiovascular risk,rs17368659
11,126431861,126431861,Blood protein levels in cardiovascular risk,rs35166255
11,47340914,47340914,Cardiovascular disease,rs10769254
11,47593023,47593023,Cardiovascular disease,rs11601694
11,55100378,55100378,Cardiovascular disease,rs74966104
11,58641214,58641214,Cardiovascular disease,rs11229555
11,61505093,61505093,Cardiovascular disease,rs7125196
11,64161743,64161743,Cardiovascular disease,rs11231711
11,65067943,65067943,Cardiovascular disease,rs3850946
11,65799248,65799248,Cardiovascular disease,rs557675
11,69312240,69312240,Cardiovascular disease,rs67330701
11,83778372,83778372,Cardiovascular disease,rs1155311
11,100739815,100739815,Cardiovascular disease,rs604723
11,103082247,103082247,Cardiovascular disease,rs2513993
11,107226051,107226051,Cardiovascular disease,rs4754196
11,111793677,111793677,Cardiovascular disease,rs12363917
11,116778201,116778201,Cardiovascular disease,rs964184
11,122656504,122656504,Cardiovascular disease,rs7129204
11,1865986,1865986,Cardiovascular disease,rs612652
11,9748015,9748015,Cardiovascular disease,rs415895
11,13248667,13248667,Cardiovascular disease,rs11605518
11,16239678,16239678,Cardiovascular disease,rs10832571
11,30727543,30727543,Cardiovascular disease,rs963837
11,32437261,32437261,Cardiovascular disease,rs3809060
11,43786724,43786724,Cardiovascular disease,rs35521277
12,121033534,121033534,Cardiovascular disease risk factors,rs3213545
12,131593515,131593515,Circulating leptin levels x sex interaction in high cardiovascular risk,rs10082903
12,124822507,124822507,Lipoprotein phospholipase A2 activity in cardiovascular disease,rs11057830
12,121000508,121000508,Blood protein levels in cardiovascular risk,rs1169306
12,4275678,4275678,Cardiovascular disease,rs76895963
12,12728121,12728121,Cardiovascular disease,rs72656645
12,20008234,20008234,Cardiovascular disease,rs2078339
12,20207394,20207394,Cardiovascular disease,rs73073694
12,26310241,26310241,Cardiovascular disease,rs11048457
12,47860570,47860570,Cardiovascular disease,rs117913411
12,48203270,48203270,Cardiovascular disease,rs17122812
12,48829758,48829758,Cardiovascular disease,rs17123349
12,50183134,50183134,Cardiovascular disease,rs4883482
12,54047714,54047714,Cardiovascular disease,rs7134677
12,69400306,69400306,Cardiovascular disease,rs315145
12,89619312,89619312,Cardiovascular disease,rs2681492
12,109968581,109968581,Cardiovascular disease,rs9634314
12,111446804,111446804,Cardiovascular disease,rs3184504
12,114940232,114940232,Cardiovascular disease,rs10850407
12,115118062,115118062,Cardiovascular disease,rs35429
12,120977112,120977112,Cardiovascular disease,rs2255531
12,121473799,121473799,Cardiovascular disease,rs10849891
12,132472014,132472014,Cardiovascular disease,rs75588192
12,133204577,133204577,Cardiovascular disease,rs36174733
13,37481632,37481632,Circulating leptin levels x sex interaction in high cardiovascular risk,rs1407608
13,42019404,42019404,Blood protein levels in cardiovascular risk,rs75416436
13,21740007,21740007,Cardiovascular disease,rs9506725
13,22596235,22596235,Cardiovascular disease,rs9317097
13,29580212,29580212,Cardiovascular disease,rs3803266
13,31671676,31671676,Cardiovascular disease,rs9603502
13,41275595,41275595,Cardiovascular disease,rs112684153
13,50532386,50532386,Cardiovascular disease,rs1239948
13,110221209,110221209,Cardiovascular disease,rs675605
13,112981842,112981842,Cardiovascular disease,rs9549328
13,113920848,113920848,Cardiovascular disease,rs41284486
13,114281830,114281830,Cardiovascular disease,rs3752105
14,73609035,73609035,Major coronary event in placebo-treated cardiovascular disease (time to event),rs147204125
14,84338144,84338144,Myocardial infarction in darapladib-treated cardiovascular disease (time to event),rs117714106
14,73609035,73609035,Major coronary event in cardiovascular disease (time to event) (darapladib treatment interaction),rs147204125
14,84338144,84338144,Myocardial infarction in cardiovascular disease (time to event) (darapladib treatment interaction),rs117714106
14,22395865,22395865,"Cardiovascular death, myocardial infarction or stroke in response to clopidogrel treatment",rs8017559
14,74935675,74935675,Blood protein levels in cardiovascular risk,rs880949
14,55334969,55334969,Blood protein levels in cardiovascular risk,rs9323280
14,103517957,103517957,Cardiovascular disease,rs2246490
14,35401887,35401887,Cardiovascular disease,rs696
14,50188639,50188639,Cardiovascular disease,rs72681869
14,50626424,50626424,Cardiovascular disease,rs2356455
14,71129630,71129630,Cardiovascular disease,rs221907
15,58386313,58386313,Cardiovascular disease risk factors,rs10468017
15,79882046,79882046,Circulating leptin levels in high cardiovascular risk,rs2562744
15,43464986,43464986,Lipoprotein phospholipase A2 activity in cardiovascular disease,rs190543502
15,43735849,43735849,Lipoprotein phospholipase A2 activity in cardiovascular disease,rs147233090
15,44000939,44000939,Lipoprotein phospholipase A2 activity in cardiovascular disease,rs11638352
15,44116203,44116203,Lipoprotein phospholipase A2 activity in cardiovascular disease,rs2733201
15,44272494,44272494,Lipoprotein phospholipase A2 activity in cardiovascular disease,rs144972973
15,81304266,81304266,Blood protein levels in cardiovascular risk,rs139879640
15,41170270,41170270,Cardiovascular disease,rs12324159
15,41878308,41878308,Cardiovascular disease,rs747780
15,61184737,61184737,Cardiovascular disease,rs4775373
15,66648746,66648746,Cardiovascular disease,rs1440371
15,67236036,67236036,Cardiovascular disease,rs7173826
15,69390577,69390577,Cardiovascular disease,rs117539635
15,74770056,74770056,Cardiovascular disease,rs11072508
15,80723086,80723086,Cardiovascular disease,rs2627308
15,90885725,90885725,Cardiovascular disease,rs1894400
16,56954132,56954132,Cardiovascular disease risk factors,rs173539
16,56955678,56955678,Cardiovascular risk factors,rs247616
16,75549741,75549741,Diarrhoea in darapladib-treated cardiovascular disease (time to event),rs151269874
16,72743326,72743326,Cardiovascular death or myocardial infarction in response to clopidogrel treatment,rs12598219
16,84305578,84305578,"Cardiovascular death, myocardial infarction or stroke in response to clopidogrel treatment",rs4782918
16,79700330,79700330,Blood protein levels in cardiovascular risk,rs11150189
16,66917880,66917880,Blood protein levels in cardiovascular risk,rs2271025
16,57380089,57380089,Blood protein levels in cardiovascular risk,rs670211
16,292771,292771,Cardiovascular disease,rs12928131
16,2036420,2036420,Cardiovascular disease,rs139491786
16,3527279,3527279,Cardiovascular disease,rs138922864
16,4087261,4087261,Cardiovascular disease,rs11647570
16,4868325,4868325,Cardiovascular disease,rs10500326
16,20381010,20381010,Cardiovascular disease,rs77924615
16,31137821,31137821,Cardiovascular disease,rs9972727
16,51794418,51794418,Cardiovascular disease,rs142076278
16,53776634,53776634,Cardiovascular disease,rs7187250
16,69397260,69397260,Cardiovascular disease,rs75086474
16,69541335,69541335,Cardiovascular disease,rs62052820
16,72067626,72067626,Cardiovascular disease,rs34042070
16,75390212,75390212,Cardiovascular disease,rs766522
16,81568607,81568607,Cardiovascular disease,rs12930850
16,89634473,89634473,Cardiovascular disease,rs2460448
17,68992525,68992525,Circulating leptin levels x sex interaction in high cardiovascular risk,rs1984722
17,65072858,65072858,Circulating leptin levels in high cardiovascular risk,rs7218921
17,65072858,65072858,Circulating leptin levels in high cardiovascular risk,rs7218921
17,28265920,28265920,Blood protein levels in cardiovascular risk,rs241771
17,58279141,58279141,Blood protein levels in cardiovascular risk,rs56378716
17,36087290,36087290,Blood protein levels in cardiovascular risk,rs2188974
17,36463294,36463294,Blood protein levels in cardiovascular risk,rs6607368
17,4722597,4722597,Blood protein levels in cardiovascular risk,rs35186877
17,77320798,77320798,Cardiovascular disease,rs1436138
17,78796097,78796097,Cardiovascular disease,rs1044486
17,81408117,81408117,Cardiovascular disease,rs6565564
17,7877701,7877701,Cardiovascular disease,rs74439044
17,30573897,30573897,Cardiovascular disease,rs58713975
17,40602398,40602398,Cardiovascular disease,rs2872812
17,45095905,45095905,Cardiovascular disease,rs2301597
17,46935905,46935905,Cardiovascular disease,rs17608766
17,47366128,47366128,Cardiovascular disease,rs1912483
17,48593060,48593060,Cardiovascular disease,rs2288276
17,49058513,49058513,Cardiovascular disease,rs68085814
17,49377153,49377153,Cardiovascular disease,rs28412876
17,58378280,58378280,Cardiovascular disease,rs2680707
17,61391581,61391581,Cardiovascular disease,rs3785837
17,63471557,63471557,Cardiovascular disease,rs4277405
17,75830325,75830325,Cardiovascular disease,rs2290769
18,31993562,31993562,Circulating leptin levels in high cardiovascular risk,rs11663063
18,773091,773091,Cardiovascular disease,rs7232858
18,1883793,1883793,Cardiovascular disease,rs313021
18,23558901,23558901,Cardiovascular disease,rs2472610
18,44514546,44514546,Cardiovascular disease,rs1877312
18,51266459,51266459,Cardiovascular disease,rs72915163
18,60252477,60252477,Cardiovascular disease,rs113602013
19,44892362,44892362,Cardiovascular disease risk factors,rs2075650
19,44892362,44892362,Cardiovascular disease risk factors,rs2075650
19,11091630,11091630,Cardiovascular disease risk factors,rs6511720
19,44908822,44908822,Cardiovascular risk factors,rs7412
19,28745485,28745485,Circulating leptin levels in high cardiovascular risk,rs2218396
19,44908822,44908822,Lipoprotein-associated phospholipase A2 activity change in response to darapladib treatment in cardiovascular disease,rs7412
19,44908822,44908822,Lipoprotein phospholipase A2 activity in cardiovascular disease,rs7412
19,11091630,11091630,Lipoprotein phospholipase A2 activity in cardiovascular disease,rs6511720
19,44908822,44908822,Ideal cardiovascular health (clinical and behavioural),rs7412
19,44912383,44912383,Ideal cardiovascular health (clinical),rs445925
19,48714854,48714854,Blood protein levels in cardiovascular risk,rs33988101
19,51018565,51018565,Blood protein levels in cardiovascular risk,rs62115757
19,6665009,6665009,Blood protein levels in cardiovascular risk,rs344560
19,18365901,18365901,Blood protein levels in cardiovascular risk,rs3195944
19,4237070,4237070,Blood protein levels in cardiovascular risk,rs4905
19,18175736,18175736,Blood protein levels in cardiovascular risk,rs200373
19,48703160,48703160,Blood protein levels in cardiovascular risk,rs492602
19,50970985,50970985,Blood protein levels in cardiovascular risk,rs11667946
19,48710274,48710274,Blood protein levels in cardiovascular risk,rs200433550
19,1832318,1832318,Cardiovascular disease,rs8102879
19,4920402,4920402,Cardiovascular disease,rs12972366
19,7257979,7257979,Cardiovascular disease,rs12978472
19,7341166,7341166,Cardiovascular disease,rs4804517
19,10222312,10222312,Cardiovascular disease,rs10409243
19,11081517,11081517,Cardiovascular disease,rs61194703
19,11186154,11186154,Cardiovascular disease,rs74179972
19,11416089,11416089,Cardiovascular disease,rs167479
19,17108295,17108295,Cardiovascular disease,rs7246865
19,18350146,18350146,Cardiovascular disease,rs113230003
19,18730347,18730347,Cardiovascular disease,rs11880800
19,44908822,44908822,Cardiovascular disease,rs7412
19,48702915,48702915,Cardiovascular disease,rs516246
19,49642643,49642643,Cardiovascular disease,rs189349094
20,58589799,58589799,Cardiovascular risk factors (age interaction),rs127430
20,63264568,63264568,Cardiovascular disease risk factors,rs1406961
20,45916409,45916409,Blood protein levels in cardiovascular risk,rs4810479
20,46113425,46113425,Blood protein levels in cardiovascular risk,rs1569723
20,23046776,23046776,Blood protein levels in cardiovascular risk,rs3176123
20,4445885,4445885,Cardiovascular disease,rs36037977
20,8641833,8641833,Cardiovascular disease,rs6039216
20,10985350,10985350,Cardiovascular disease,rs1887320
20,32629151,32629151,Cardiovascular disease,rs4911250
20,40551182,40551182,Cardiovascular disease,rs1883711
20,44166512,44166512,Cardiovascular disease,rs6031431
20,48791877,48791877,Cardiovascular disease,rs2208589
20,51492442,51492442,Cardiovascular disease,rs6021247
20,59131469,59131469,Cardiovascular disease,rs7267618
20,63852557,63852557,Cardiovascular disease,rs2478981
20,64080106,64080106,Cardiovascular disease,rs8126001
21,43781951,43781951,Blood protein levels in cardiovascular risk,rs35285321
21,43569666,43569666,Cardiovascular disease,rs4818833
21,43339560,43339560,Cardiovascular disease,rs12627514
21,15204463,15204463,Cardiovascular disease,rs2823139
22,34618748,34618748,Circulating leptin levels in high cardiovascular risk,rs5755145
22,20057896,20057896,Cardiovascular disease,rs174877
22,29061594,29061594,Cardiovascular disease,rs134557
X,29622701,29622701,Cardiovascular risk factors (age interaction),rs7890572
X,129601222,129601222,Diarrhoea in darapladib-treated cardiovascular disease (time to event),rs16999497
X,129737601,129737601,Blood protein levels in cardiovascular risk,rs2050011
